UOC
UBS O'Connor Portfolio holdings
AUM
$1.93B
1-Year Return
38.75%
This Quarter Return
+15.38%
1 Year Return
+38.75%
3 Year Return
+182.42%
5 Year Return
+480.25%
10 Year Return
+1,573.29%
AUM
$3.3B
AUM Growth
-$463M
(-12%)
Cap. Flow
-$632M
Cap. Flow
% of AUM
-19.12%
Top 10 Holdings %
Top 10 Hldgs %
73.53%
Holding
460
New
59
Increased
65
Reduced
85
Closed
138
Top Buys
| 1 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
$405M |
| 2 |
DFS
Discover Financial Services
DFS
|
$209M |
| 3 |
BECN
Beacon Roofing Supply, Inc.
BECN
|
$195M |
| 4 |
HEES
H&E Equipment Services
HEES
|
$103M |
| 5 |
JWN
Nordstrom
JWN
|
$96.6M |
Top Sells
| 1 |
Kellanova
K
|
$305M |
| 2 |
HCP
HashiCorp, Inc. Class A Common Stock
HCP
|
$235M |
| 3 |
SMAR
Smartsheet Inc.
SMAR
|
$216M |
| 4 |
EDR
Endeavor Group Holdings, Inc.
EDR
|
$144M |
| 5 |
SUM
Summit Materials, Inc. Class A Common Stock
SUM
|
$103M |
Sector Composition
| 1 | Energy | 21.95% |
| 2 | Financials | 16.66% |
| 3 | Healthcare | 15.59% |
| 4 | Technology | 13.54% |
| 5 | Industrials | 12.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
176
IQVIA
IQV
$31.9B
| $882K | 0.03% |
+5,000
| New | +$882K |
|
177
BridgeBio Pharma
BBIO
$10.2B
| $881K | 0.03% |
25,492
-35,626
| -58% | -$1.23M |
|
178
Edgewise Therapeutics
EWTX
$1.64B
| $880K | 0.03% |
+40,014
| New | +$880K |
|
179
AnaptysBio
ANAB
$613M
| $875K | 0.03% |
+47,051
| New | +$875K |
|
180
Skillsoft
SKIL
$132M
| $802K | 0.02% |
41,692
| – | – |
|
181
Edwards Lifesciences
EW
$47.5B
| $791K | 0.02% |
10,920
+1,160
| +12% | +$84.1K |
|
182
UWM Holdings
UWMC
$1.38B
| $781K | 0.02% |
143,000
| – | – |
|
183
enVVeno Medical
NVNO
$14.9M
| $779K | 0.02% |
296,031
| – | – |
|
184
Akero Therapeutics
AKRO
$3.58B
| $761K | 0.02% |
+18,800
| New | +$761K |
|
185
Alcon
ALC
$39.6B
| $759K | 0.02% |
8,000
-6,039
| -43% | -$573K |
|
186
Syndax Pharmaceuticals
SNDX
$1.47B
| $730K | 0.02% |
59,438
-30,794
| -34% | -$378K |
|
|
SPKL
187
Spark I Acquisition Corp
SPKL
$94.8M
| $722K | 0.02% |
66,832
| – | – |
|
188
Disc Medicine
IRON
$2.11B
| $676K | 0.02% |
13,621
-636
| -4% | -$31.6K |
|
189
Neurogene
NGNE
$285M
| $656K | 0.02% |
56,015
+23,281
| +71% | +$273K |
|
190
Tesla
TSLA
$1.13T
| $648K | 0.02% |
2,500
+2,000
| +400% | +$518K |
|
191
Protagonist Therapeutics
PTGX
$3.77B
| $645K | 0.02% |
+13,340
| New | +$645K |
|
192
Advanced Micro Devices
AMD
$245B
| $616K | 0.02% |
+6,000
| New | +$616K |
|
|
OCFT
193
OneConnect Financial Technology
OCFT
$281M
| $558K | 0.02% |
+83,257
| New | +$558K |
|
194
Vera Therapeutics
VERA
$1.54B
| $541K | 0.02% |
22,525
+10,994
| +95% | +$264K |
|
|
ONC
195
BeOne Medicines Ltd. American Depositary Shares
ONC
$37.6B
| $512K | 0.02% |
1,880
-14,319
| -88% | -$3.9M |
|
196
TAL Education Group
TAL
$6.17B
| $489K | 0.01% |
+37,000
| New | +$489K |
|
197
AstraZeneca
AZN
$253B
| $486K | 0.01% |
6,611
-54,836
| -89% | -$4.03M |
|
198
Roivant Sciences
ROIV
$8.82B
| $432K | 0.01% |
42,819
-136,447
| -76% | -$1.38M |
|
|
WRD
199
WeRide Inc. American Depositary Shares
WRD
$2.58B
| $425K | 0.01% |
+31,350
| New | +$425K |
|
200
Janux Therapeutics
JANX
$1.44B
| $406K | 0.01% |
+15,040
| New | +$406K |
|